Human cytoplasmic polyadenylation element binding protein and uses thereof
AssigneeThe Board of Trustees of the University of Arkansas System
InventorAngus M. MacNicol
Life of this patent
Estimating the term…
Abstract
The present invention provides genomic and cDNA encoding human cytoplasmic polyadenylation element binding protein, expression vectors comprising human cytoplasmic polyadenylation element binding protein cDNA and host cells that contain the expression vectors. Also provided are recombinant human cytoplasmic polyadenylation element binding protein and polypeptides derived thereof.
Claims2
A recombinant human cytoplasmic polyadenylation element binding protein, wherein said protein has the amino acid sequence of SEQ ID NO:
- 3 or 4.
A method of screening for a compound that increases or decreases the RNA binding activity of a human cytoplasmic polyadenylation element binding protein comprising SEQ ID NO:
- 3 or 4, comprising the steps of:
- (a) contacting said human cytoplasmic polyadenylation element binding protein with an RNA probe comprising the cytoplasmic polyadenylation element sequence in the presence of said compound, and
- (b) determining the cytoplasmic polyadenylation element sequence-specific binding activity of said polyadenylation element binding protein, wherein an increase in said binding activity indicates that said compound increases the RNA binding activity of the human cytoplasmic polyadenylation element binding protein, and wherein a decrease in said binding activity indicates that said compound decreases the RNA binding activity of the human cytoplasmic polyadenylation element binding protein.
Dependencies are inferred from the claim text.